Review
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 105140
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.105140
Figure 2
Figure 2 Concise overview of N6-methyladenosine modifiers’ functions in hepatobiliary carcinoma. Diverse N6-methyladenosine (m6A)-related regulators, through aberrant m6A modifications, specifically target various genes or pathways, influencing the onset and progression of the tumor.